Bryce Point Capital LLC Takes Position in Azenta, Inc. (NASDAQ:AZTA)

Bryce Point Capital LLC purchased a new position in shares of Azenta, Inc. (NASDAQ:AZTAFree Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 7,687 shares of the company’s stock, valued at approximately $384,000.

A number of other hedge funds have also added to or reduced their stakes in the company. Picton Mahoney Asset Management boosted its holdings in shares of Azenta by 305.7% in the 4th quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock valued at $35,000 after purchasing an additional 532 shares in the last quarter. Headlands Technologies LLC bought a new stake in shares of Azenta during the 4th quarter worth $40,000. KBC Group NV boosted its stake in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after buying an additional 698 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Azenta in the fourth quarter valued at about $200,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Azenta by 14.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company’s stock worth $225,000 after acquiring an additional 576 shares in the last quarter. 99.08% of the stock is owned by institutional investors.

Azenta Stock Performance

Shares of NASDAQ AZTA opened at $29.12 on Friday. The firm has a 50 day moving average price of $43.01 and a two-hundred day moving average price of $45.77. The stock has a market cap of $1.33 billion, a P/E ratio of -9.77 and a beta of 1.52. Azenta, Inc. has a 52-week low of $27.93 and a 52-week high of $63.58.

Azenta (NASDAQ:AZTAGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. Analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AZTA has been the topic of several research reports. Evercore ISI lifted their price target on shares of Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a report on Thursday, February 6th. Stephens reaffirmed an “overweight” rating and set a $60.00 target price on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen upgraded Azenta to a “hold” rating in a research note on Thursday, February 27th. Finally, Needham & Company LLC raised their price objective on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, February 6th.

View Our Latest Stock Report on Azenta

Azenta Company Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Articles

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTAFree Report).

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.